BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Tiffany CL Wong, Chung-Mau Lo, James YY Fung. Emerging drugs for prevention of T-cell mediated rejection in liver and kidney transplantationExpert Opinion on Emerging Drugs 2017; 22(2): 123 doi: 10.1080/14728214.2017.1330884
2
Rong-Kun Chang, Neil Mathias, Munir A. Hussain. Biopharmaceutical Evaluation and CMC Aspects of Oral Modified Release FormulationsThe AAPS Journal 2017; 19(5): 1348 doi: 10.1208/s12248-017-0112-6
3
Y Li, X Feng. Efficacy and safety of tacrolimus in systemic lupus erythematosus patients with refractory thrombocytopenia: a retrospective studyLupus 2018; 27(1): 60 doi: 10.1177/0961203317711011
4
Satish Chandrashekaran, Stacy A. Crow, Sadia Z. Shah, Chris J. Arendt, Cassie C. Kennedy. Immunosuppression for Lung Transplantation: Current and FutureCurrent Transplantation Reports 2018; 5(3): 212 doi: 10.1007/s40472-018-0199-4
5
Mark Cattral, Sean Luke, Michael J. Knauer, Andrea Norgate, Jeffrey Schiff, Norman Muirhead, Patrick P. Luke. Randomized open-label crossover assessment of Prograf vs Advagraf on immunosuppressant pharmacokinetics and pharmacodynamics in simultaneous pancreas-kidney patientsClinical Transplantation 2018; 32(2): e13180 doi: 10.1111/ctr.13180
6
Rolf Anton Klaasen, Stein Bergan, Sara Bremer, Lina Daleq, Anders Mikal Andersen, Karsten Midtvedt, Morten Heier Skauby, Nils Tore Vethe. Longitudinal Study of Tacrolimus in Lymphocytes During the First Year After Kidney TransplantationTherapeutic Drug Monitoring 2018; 40(5): 558 doi: 10.1097/FTD.0000000000000539